Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2018 Photo Supplied
Kovsie athletes ready for Varsity athletics TSepang Sello
Ts’epang Sello, one of the Kovsie contenders for a medal at Friday’s Varsity athletics meeting.

Ts’epang Sello, one of the Kovsie contenders
for a medal at Friday’s Varsity athletics meeting.
Photo: Supplied

The University of the Free State will hope to start developing their next Wayde van Niekerk when the first Varsity athletics meeting takes place on Friday at the Tuks Athletics Stadium in Pretoria.

The second meeting is on 23 March, also in Pretoria.

Thirteen members (five men and eight women) of the Kovsie team of 25 are still under the age of 21.

The hope for medals among the men would be on Sefako Mokhosoa (triple jump), Hendrik Maartens, and Tsebo Matsoso (both 200 m). Mokhosoa, who represented South Africa last year at the Southern Region Championships, is in red-hot form and achieved a personal best of 16.13 m at the Motheo/Xhariep meeting two weeks ago. This is currently the third best distance in the country for 2018.

Maartens would like to go one step further. In last year’s final Varsity meeting, he finished second in 20.62. Great things are expected of Matsoso, a first-year student who competed at the African Junior Championship in 2017. Last year, he was one of the top athletes at school level by winning the SA title in a time of 21.14. 

Ts’epang Sello (800 m) and Elmé Smith (100 m and 200 m) will lead the charge for the women. Sello already came close to her personal best (2:09.8) this year, while Smith has also been running fast times. Her best this year was 11.88 (100 m) and 24.53 (200 m). 

Tyler Beling (1 500 m) is another first-year student who is showing great potential. She obtained a fourth position at last weekend’s CAA Southern Region Cross-country Championships. Maryke Brits (100 m hurdles and long jump) is a possible medallist, despite running her first event for the year on Wednesday night.

The meeting starts at 17:15 and will be broadcast on SuperSport 5.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept